The Canadian market has been navigating a period of anticipation, particularly influenced by global monetary policy signals from events like the U.S. Federal Reserve's Jackson Hole symposium. As investors await clearer direction on interest rates, it's an opportune moment to explore lesser-known stocks that could offer promising potential amidst these evolving economic conditions. In this article, we will uncover three undiscovered gems in Canada that may be well-positioned for growth within your investment portfolio.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
TWC Enterprises | 6.74% | 10.99% | 25.68% | ★★★★★★ |
Taiga Building Products | NA | 6.05% | 10.50% | ★★★★★★ |
Tornado Global Hydrovacs | 14.62% | 24.52% | 64.90% | ★★★★★☆ |
Reconnaissance Energy Africa | NA | 31.73% | -6.92% | ★★★★★☆ |
Mako Mining | 22.90% | 38.12% | 54.79% | ★★★★★☆ |
Firan Technology Group | 17.91% | 3.75% | 23.32% | ★★★★★☆ |
Pizza Pizza Royalty | 15.66% | 3.64% | 3.95% | ★★★★☆☆ |
Firm Capital Mortgage Investment | 57.73% | 9.38% | 5.91% | ★★★★☆☆ |
Queen's Road Capital Investment | 7.20% | 22.14% | 22.20% | ★★★★☆☆ |
Genesis Land Development | 53.32% | 25.58% | 47.05% | ★★★★☆☆ |
Let's explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada with a market cap of CA$453.17 million.
Operations: Cipher Pharmaceuticals generates revenue primarily from its specialty pharmaceuticals segment, which brought in CA$22.16 million.
Cipher Pharmaceuticals, trading at 53.2% below its estimated fair value, has no debt compared to five years ago when the debt-to-equity ratio was 50.1%. Despite a negative earnings growth of -19.4% over the past year, earnings are forecast to grow by 3.81% annually. For Q2 2024, revenue stood at US$5.3 million with net income of US$3 million and basic EPS from continuing operations at US$0.12, consistent with last year’s figures.
Understand Cipher Pharmaceuticals' track record by examining our Past report.
Simply Wall St Value Rating: ★★★★★★
Overview: Hammond Power Solutions Inc., along with its subsidiaries, focuses on designing, manufacturing, and selling various transformers across Canada, the United States, Mexico, and India with a market cap of CA$1.43 billion.
Operations: Hammond Power Solutions generates CA$754.37 million in revenue from the manufacture and sale of transformers. The company's market cap is CA$1.43 billion.
Hammond Power Solutions, a lesser-known Canadian electrical company, has shown impressive financial performance. Over the past year, its earnings grew by 12.3%, outpacing the industry’s 6.5% growth rate. The firm’s debt-to-equity ratio dropped from 27.7% to just 5% over five years, indicating strong financial health. Recently reported Q2 sales were CAD 197 million, up from CAD 172 million last year, with net income rising to CAD 23 million from CAD 13 million previously.
Explore historical data to track Hammond Power Solutions' performance over time in our Past section.
Simply Wall St Value Rating: ★★★★★☆
Overview: TerraVest Industries Inc. manufactures and sells goods and services to energy, agriculture, mining, transportation, and other markets in Canada and the United States with a market cap of CA$1.88 billion.
Operations: TerraVest Industries generates revenue primarily from four segments: HVAC and Containment Equipment (CA$292.90 million), Compressed Gas Equipment (CA$243.77 million), Service (CA$201.78 million), and Processing Equipment (CA$117.58 million). The Corporate segment shows a negative contribution of CA$0.93 million, impacting overall profitability.
TerraVest Industries, a small cap, reported third-quarter revenue of C$238.13 million, up from C$150.36 million last year. Net income rose to C$11.92 million from C$7.97 million, with basic earnings per share at C$0.63 compared to C$0.45 previously. The company repurchased shares in 2024 and has high-quality past earnings despite significant insider selling recently noted and a net debt to equity ratio of 42%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com